|
Sign In to gain access to subscriptions and/or personal tools.
|
This version was published on September
1, 2006
Journal of Biomolecular Screening, Vol. 11, No. 6,
586-598 (2006)
DOI: 10.1177/1087057106289406
Multiparametric Cell Cycle Analysis by Automated Microscopy
Fabio Gasparri
Biology Department, Oncology, Nerviano Medical Sciences, Nerviano, Italy
Paolo Cappella
Biology Department, Oncology, Nerviano Medical Sciences, Nerviano, Italy
Arturo Galvani
Biology Department, Oncology, Nerviano Medical Sciences, Nerviano, Italy
Cell cycle analysis using flow cytometry (FC) to measure cellular DNA content is a common procedure in drug mechanism of action studies. Although this technique lends itself readily to cell lines that grow in suspension, adherent cell cultures must be resuspended in a cumbersome and potentially invasive procedure that normally involves trypsinization and mechanical agitation of monolayer cultures. High-content analysis (HCA), an automated microscopy-based technology, is well suited to analysis of monolayer cell cultures but provides intrinsically less accurate determination of cellular DNA content than does FC and thus is not the method of choice for cell cycle analysis. Using Cellomicss ArrayScanTM reader, the authors have developed a 4-color multiparametric HCA approach for cell cycle analysis of adherent cells based on detection of DNA content (4,6-diamidino-2-phenylindole [DAPI] fluorescence), together with the known cell cycle markers bromo-2-deoxyuridine (BrdU) incorporation, cyclin B1 expression, and histone H3 (Ser28) phosphorylation within a single cell population. Considering all 4 markers together, a reliable and accurate quantification of cell cycle phases was possible, as compared with flow cytometric analysis. Using this assay, specific cell cycle blocks induced by treatment with thymidine, paclitaxel, or nocodazole as test drugs were easily monitored in adherent cultures of U-2 OS osteosarcoma cells.
Key Words: Cell-based assays ArrayScanTM high-content analysis cell-cycle U-2 OS
References
- Gibbs JB: Mechanism-based target identification and drug discovery in cancer research. Science 2000;287: 1969-1973.[Abstract/Free Full Text]
- Giuliano KA, Haskins JR, Taylor DL: Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1: 565-577.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ: Multidimensional drug profiling by automated microscopy. Science 2004;306: 1194-1198.[Abstract/Free Full Text]
- Pozarowsky P, Darzynkiewicz Z: Analysis of cell cycle by flow cytometry. Methods Mol Biol 2004;281: 301-311.[Medline]
[Order article via Infotrieve]
- Faretta M, Bergamaschi D, Taverna S, Ronzoni S, Pantarotto M, Mascellani E, et al: Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis. Cytometry 1998;31: 53-59.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM, et al: Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 1998;32: 71-77.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Gorczyca W, Sarode V, Juan G, Melamed MR, Darzynkiewicz Z: Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Mod Pathol 1997;10: 457-462.[ISI][Medline]
[Order article via Infotrieve]
- Soini AE, Kuusisto A, Meltola NJ, Soini E, Seveus L: A new technique for multiparameter imaging microscopy: use of long decay time photoluminescent labels enables multiple color immunocytochemistry with low channel-to-channel crosstalk. Microsc Res Tech 2003;62: 396-407.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Wahlby C, Erlandsson F, Bengtsson E, Zetterberg A: Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei. Cytometry 2002;47: 32-41.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Minguez JM, Giuliano KA, Balachandran R, Madiraju C, Curran DP, Day BW: Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)-discodermolide. Mol Cancer Ther 2002;1: 1305-1313.[Abstract/Free Full Text]
- Sherr CJ: Cancer cell cycles. Science 1996;274: 1672-1677.[Abstract/Free Full Text]
- Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, Brinkley BR, et al: Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 1997;106: 348-360.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Goto H, Yasui Y, Nigg EA, Inagaki M: Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 2002;7: 11-17.[Abstract]
- Dolbeare F, Gratzner H, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. PNAS 1983;80: 5573-5577.[Abstract/Free Full Text]
- Trent JM, Gerner E, Broderick R, Crossen PE: Cell cycle analysis using bromodeoxyuridine: comparison of methods for analysis of total cell transit time. Cancer Genet Cytogenet 1986;19: 43-50.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Gonchoroff NJ, Katzmann JA, Currie RM, Evans EL, Houck DW, Kline BC, et al: S-phase detection with an antibody to bromodeoxyuridine: role of DNase pretreatment. J Immunol Methods 1986;93: 97-101.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Gasparri F, Mariani M, Sola F, Galvani A: Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader. J Biomol Screen 2004;9: 232-243.[Abstract]
- Carayon P, Bord A: Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J Immunol Methods 1992;147: 225-230.[ISI][Medline]
[Order article via Infotrieve]
- Tobey RA, Anderson EC, Petersen DF: The effect of thymidine on the duration of G1 in Chinese hamster cells. J Cell Biol 1967;35: 53-59.[Abstract/Free Full Text]
- Bostock CJ, Prescott DM, Kirkpatrick JB: An evaluation of the double thymidine block for synchronizing mammalian cells at the G1-S border. Exp Cell Res 1971;68: 163-168.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Fuchs DA, Johnson RK: Cytologic evidence that Taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep 1978;62: 1219-1222.[ISI][Medline]
[Order article via Infotrieve]
- Kelling J, Sullivan K, Wilson L, Jordan MA: Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Res 2003;63: 2794-2801.[Abstract/Free Full Text]
- Sentein P: Action of nocodazole on the mechanisms of segmentation mitosis. Cell Biol Int Rep 1977;1: 503-509.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Samson F, Donoso JA, Heller-Bettinger I, Watson D, Himes RH: Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport. J Pharmacol Exp Ther 1979;208: 411-417.[Abstract/Free Full Text]
- Sihn CR, Suh EJ, Lee KH, Kim SH: Sec13 induces genomic instability in U2OS cells. Exp Mol Med 2005;37: 255-260.[ISI][Medline]
[Order article via Infotrieve]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. O'Brien, G. Cavet, A. Pandita, X. Hu, L. Haydu, S. Mohan, K. Toy, C. S. Rivers, Z. Modrusan, L. C. Amler, et al.
Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast Cancer
Cancer Res.,
July 1, 2008;
68(13):
5380 - 5389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barbe, E. Lundberg, P. Oksvold, A. Stenius, E. Lewin, E. Bjorling, A. Asplund, F. Ponten, H. Brismar, M. Uhlen, et al.
Toward a Confocal Subcellular Atlas of the Human Proteome
Mol. Cell. Proteomics,
March 1, 2008;
7(3):
499 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sartore-Bianchi, F. Gasparri, A. Galvani, L. Nici, J. W. Darnowski, D. Barbone, D. A. Fennell, G. Gaudino, C. Porta, and L. Mutti
Bortezomib Inhibits Nuclear Factor-{kappa}B Dependent Survival and Has Potent In vivo Activity in Mesothelioma
Clin. Cancer Res.,
October 1, 2007;
13(19):
5942 - 5951.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|